Clinics, pharmacies and hospitals interested in administering COVID-19 vaccine must enroll in the federal COVID-19 Vaccination Program. The Washington State Department of Health (DOH) is organizing the enrollment process for Washington state providers. To enroll, complete the COVID-19 Provider Inquiry Form on the DOH COVID-19 Vaccination Program Enrollment webpage. This form is only for clinics, pharmacies, or hospitals interested in administering COVID-19 vaccines. A DOH representative will follow up with your organization as soon as possible. You can use the COVID-19 Provider Enrollment Guide (PDF) to help you through the enrollment process.
SRHD is now operating as a COVID-19 vaccine depot for DOH. Providers in Spokane and surrounding counties who are unable to meet minimum order quantities required by the Washington State Immunization Information System (WAIIS) can instead order smaller quantities of COVID-19 vaccine from designated depots, like SRHD. This allows more providers to get vaccine and limits vaccine transit times, which reduces risk of waste.
For questions, please contact the SRHD Immunization Assessment and Promotion team at COVIDVaccine@srhd.org.
How to Order and Provider Responsibilities
If you are interested in ordering vaccine from SRHD, first enroll in the COVID-19 Vaccination Program. See details in the “COVID-19 Vaccination Program Enrollment” section above. Once enrolled, please do the following:
Contact SRHD 72 hours in advance and coordinate vaccine transport by filling out the Depot Request Form.
Follow vaccine transport guidance if pick up from the depot.
Schedule vaccine appointments and administer vaccine.
Maintain accurate inventory in the Washington State Immunization Information System (WAIIS) and VaccineFinder.
Report any temperature excursion that happen during transport. If excursion occurs, follow the steps outlined in the COVID-19 vaccine temperature excursion guide and contact the manufacturer to assess vaccines’ viability. Immediately report excursion to email@example.com.
Please report all positive COVID-19 cases for Spokane County residents by fax at 509.324.3623. It is unnecessary to report cases with labs performed by LabCorp, Quest, Northwest Laboratory, InCyte and Interpath as these are reported automatically by the performing laboratory. While cases are also automatically electronically reported to Spokane Regional Health District (SRHD) by Sacred Heart, Holy Family, Deaconess and Valley Hospital, hospitals must still report hospitalized cases and deaths separately.
When reporting, please include complete patient demographics (birthdate, address, phone, race/ethnicity), collection date and the specific test method used.
Breakthrough Case Reporting Most breakthrough cases are now being identified automatically for patients whose immunization record is in the WA Immunization Information System (WA IIS). However, patients who were vaccinated by federal agencies (VA, military, etc.) or were vaccinated out of state are likely not in the system.
Healthcare facilities only need to report breakthrough cases for patients whose immunization record is not in WA IIS. Please use this COVID-19 Case Report Form and provide a copy of patient's vaccination documentation. (This form may also be used to report non-breakthrough cases.)
Rapid Test Protocols Facilities that are using rapid tests must report both their positive AND negative test results to the Washington State Department of Health (DOH). You may use this reporting form (one page per case). Please separate positive and negative tests into separate batches before sending. (Follow these instructions for submitting reports to the state.) The state will then forward positive results to the appropriate county.
Long Term Care Facilities, please see the Infection Prevention and Control section below for instructions on reporting cases.
Testing Information for Patients
Please do not advise patients to call SRHD for consultation or testing. SRHD does not provide testing nor do we have nurses on staff to assess a patient’s clinical condition. Please advise patients according to the documents below:
Test all patients with new onset of symptoms consistent with COVID-19, regardless of their age or health status. COVID-19 patients may present with cough, shortness of breath, fever and chills. However, many patients often only experience mild symptoms, including muscle pain, fatigue, congestion, headache, sore throat or new loss of taste or smell.
Rapidly testing all patients with symptoms consistent with COVID-19 is critical to identifying and isolating cases, quarantining their contacts, and suppressing community spread.
Limit testing of asymptomatic persons to those with exposure, including close contacts and individuals exposed during an outbreak in a congregate setting. (Note: close contacts still need to remain in quarantine for 14 days after their last date of exposure even with a negative test.)
The guidance further outlines additional asymptomatic people who can be considered for testing if adequate testing supplies are available. Please consult the full document.
Continue to educate all patients you test, including emphasizing isolation for ill persons and quarantine for exposed contacts:
The preferred diagnostic test is a PCR-based test.
Specimens sent to CLIA-certified labs for PCR-based tests have demonstrated higher sensitivity and fewer false negatives than point-of-care tests.
Additionally, serology or antibody tests are not recommended for making a COVID-19 diagnosis or to reliably determine whether someone has experienced a past infection with COVID-19 (more below).
The guidance further outlines the types of swabs preferred for COVID-19 testing and appropriate specimen collection and storage/transport, including self-collected nasal swabs under healthcare provider observation. Please consult the full document.
* Read the CDC overview of testing for SARS-CoV-2 (COVID-19) here.
Isolation & Quarantine Guidelines
Please refer to the following for an overview of COVID-19 isolation guidelines.
Patients must isolate while awaiting test results. If COVID-19 is highly suspected, the patient’s household members should be strongly advised to quarantine as well.
Patients with COVID-19 must isolate for a full 10 days after their symptom onset or positive test result (returning to normal activities on day 11) and fever must be absent for 24 hours without the use of fever-reducing medications.
Severe illness requiring hospitalization or severely immunocompromised patients must isolate for a full 20 days after symptom onset.
Patients who are asymptomatic at the time of their positive test who later develop symptoms must isolate for 10 days after symptom onset, not the date of their positive test.
After someone has met initial isolation criteria, they should not undergo repeat COVID-19 testing
Please refer to the following for an overview of COVID-19 quarantine guidelines.
People with known exposure must quarantine for
14 days after exposure (recommended); or,
10 days after exposure as long as no symptoms have developed and the exposed person adheres to strict masking and distancing and continues monitor symptoms through day 14.
Mask usage (by either the case or the exposed person) does not negate the need for quarantine in the exposed person, except in exposed healthcare workers wearing proper PPE.
Household members of a COVID-19 case must quarantine for 14 or 10 days (as explained above) beyond the day of last contact with the case while they were infectious. This can be as long as 20-24 days (10 days of infectiousness for case plus 10 or 14 days of standard quarantine after exposure). Note that this period starts over for uninfected household members as new cases within the household are identified.
Household members of a single exposed person (such as a child exposed in school) do not need to quarantine with the exposed person unless the exposed person develops symptoms and/or tests positive